DE60105035D1 - 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol und seine therapeutische verwendungen - Google Patents
1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol und seine therapeutische verwendungenInfo
- Publication number
- DE60105035D1 DE60105035D1 DE60105035T DE60105035T DE60105035D1 DE 60105035 D1 DE60105035 D1 DE 60105035D1 DE 60105035 T DE60105035 T DE 60105035T DE 60105035 T DE60105035 T DE 60105035T DE 60105035 D1 DE60105035 D1 DE 60105035D1
- Authority
- DE
- Germany
- Prior art keywords
- skin
- homopregnacalciferol
- 1alpha
- methylene
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65782800A | 2000-09-08 | 2000-09-08 | |
US657828 | 2000-09-08 | ||
PCT/US2001/018710 WO2002020021A1 (en) | 2000-09-08 | 2001-06-11 | 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60105035D1 true DE60105035D1 (de) | 2004-09-23 |
DE60105035T2 DE60105035T2 (de) | 2005-08-18 |
Family
ID=24638806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60105035T Expired - Lifetime DE60105035T2 (de) | 2000-09-08 | 2001-06-11 | 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol und seine therapeutische verwendungen |
Country Status (16)
Country | Link |
---|---|
US (2) | US6440953B1 (de) |
EP (1) | EP1315504B1 (de) |
JP (1) | JP4022144B2 (de) |
KR (1) | KR100672886B1 (de) |
CN (1) | CN1473048A (de) |
AT (1) | ATE273709T1 (de) |
AU (2) | AU2001275445B2 (de) |
BR (1) | BR0113703A (de) |
CA (1) | CA2420026C (de) |
DE (1) | DE60105035T2 (de) |
ES (1) | ES2227215T3 (de) |
IL (2) | IL154699A0 (de) |
MX (1) | MXPA03001969A (de) |
NZ (1) | NZ524657A (de) |
PT (1) | PT1315504E (de) |
WO (1) | WO2002020021A1 (de) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020183288A1 (en) * | 1995-04-03 | 2002-12-05 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
US6316642B1 (en) * | 1997-03-17 | 2001-11-13 | Wisconsin Alumni Research Foundation | 26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds |
US6392071B1 (en) * | 1997-03-17 | 2002-05-21 | Wisconsin Alumni: Research Foundation | 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
US6989377B2 (en) | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
US6358939B1 (en) * | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
NZ533424A (en) * | 2001-12-13 | 2006-08-31 | Wisconsin Alumni Res Found | Vitamin D derivative, methods of purifying and uses in treating psoriasis, cancer, autoimmune diseases, inflammatory diseases, skin conidtions and renal ostepdystrophy |
US6627622B2 (en) | 2002-02-18 | 2003-09-30 | Wisconsin Alumni Research Foundation | (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
US6566352B1 (en) * | 2002-02-18 | 2003-05-20 | Wisconsin Alumni Research Foudation | 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
DE60310050T2 (de) | 2002-03-29 | 2007-07-05 | Wisconsin Alumni Research Foundation, Madison | Ein verfahren zur herstellung von 1-alpha-hydroxy-2-methylen-19-nor-homopregnacalciferol |
US6846811B2 (en) * | 2002-04-22 | 2005-01-25 | Wisconsin Alumni Research Foundation | (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
JP4469794B2 (ja) | 2003-02-25 | 2010-05-26 | 神戸天然物化学株式会社 | ビタミンd誘導体を合成するための新規な中間体 |
EP1656157B1 (de) * | 2003-08-20 | 2011-12-21 | Wisconsin Alumni Research Foundation | 2-methylen-19-nor-vitamin d2-verbindungen |
US7704980B2 (en) * | 2003-10-08 | 2010-04-27 | Wisconsin Alumni Research Foundation | Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds |
WO2005051323A2 (en) * | 2003-11-25 | 2005-06-09 | Wisconsin Alumni Research Foundation | Vitamin d analogs for obesity prevention and treatment |
US7053075B2 (en) * | 2003-11-25 | 2006-05-30 | Deluca Hector F | Methods for reducing body fat using vitamin D compounds |
US8404667B2 (en) * | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
US7915242B2 (en) * | 2004-02-17 | 2011-03-29 | Wisconsin Alumni Research Foundation | Vitamin D receptor antagonists and their use in treating asthma |
US7214671B2 (en) * | 2004-02-19 | 2007-05-08 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases |
US7713951B2 (en) * | 2004-04-09 | 2010-05-11 | Wisconsin Alumni Research Foundation | 2-alkylidene-18,19-dinor-vitamin D compounds |
MX2007006094A (es) * | 2004-11-22 | 2007-07-11 | Wisconsin Alumni Res Found | 2-metilen-19,21-dinor-1a-hidroxi-bishomopregnacalciferol. |
WO2006057886A2 (en) * | 2004-11-22 | 2006-06-01 | Wisconsin Alumni Research Foundation | 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
AU2005309819A1 (en) * | 2004-11-22 | 2006-06-01 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-(20S)-1alpha-hydroxy-trishomopregnacalciferol |
MX2007006090A (es) | 2004-11-22 | 2007-07-11 | Wisconsin Alumni Res Found | 2-metilen-19-nor-(20r)-1a-hidroxi-bishomopregnacalciferol. |
WO2006057932A2 (en) * | 2004-11-22 | 2006-06-01 | Wisconsin Alumni Research Foundation | 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES |
JP2008520706A (ja) * | 2004-11-22 | 2008-06-19 | ウィスコンシン・アルムニ・リサーチ・ファウンデーション | 2α−メチル−19−ノル−1α−ヒドロキシ−ホモプレグナカルシフェロール及びその使用 |
US7241751B2 (en) * | 2004-11-22 | 2007-07-10 | Wisconsin Alumi Research Foundation | 2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses |
ATE469127T1 (de) * | 2004-11-22 | 2010-06-15 | Wisconsin Alumni Res Found | 17,20(z)-dehydro-vitamin-d-analoge und deren verwendungen |
US20060195353A1 (en) * | 2005-02-10 | 2006-08-31 | David Goldberg | Lead generation method and system |
ATE554774T1 (de) * | 2005-02-11 | 2012-05-15 | Wisconsin Alumni Res Found | 2-methylen-19-nor-(20s-24epi)-1alpha,25- dihydrovitamin-d2 |
CA2597624C (en) * | 2005-02-11 | 2012-08-14 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-(20s-24s)-1.alpha.,25-dihydroxyvitamin-d2 |
JP2008538214A (ja) * | 2005-03-29 | 2008-10-16 | ウイスコンシン アラムニ リサーチ ファンデーション | 2−メチレン−19−ノル−(23S)−25−デヒドロ−1α−ヒドロキシビタミンD3−26,23−ラクトンおよび2−メチレン−19−ノル−(23R)−25−デヒドロ−1α−ヒドロキシビタミンD3−26,23−ラクトン |
WO2006119309A2 (en) | 2005-05-03 | 2006-11-09 | Wisconsin Alumni Research Foundation | 19,26,27-TRINOR-1α,25-DIHYDROXYVITAMIN D3 COMPOUNDS |
CA2620354C (en) * | 2005-08-30 | 2013-02-05 | Wisconsin Alumni Research Foundation | Des-c,d analogs of 1.alpha.,25-dihydroxy-19-norvitamin d3 |
NZ567438A (en) * | 2005-09-22 | 2010-11-26 | Wisconsin Alumni Res Found | 19,23,24,25,26,27-Hexanor-1alpha-hydroxyvitamin D3 |
US7803789B2 (en) | 2006-02-02 | 2010-09-28 | Wisconsin Alumni Research Foundation | Vitamin D analog—RAK, methods and uses thereof |
US7528122B2 (en) * | 2006-02-02 | 2009-05-05 | Wisconsin Alumni Research Foundation | Vitamin D analog—NEL, methods and uses thereof |
US8193169B2 (en) * | 2006-04-06 | 2012-06-05 | Wisconsin Alumni Research Foundation | (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs |
JP2009532458A (ja) * | 2006-04-06 | 2009-09-10 | ウイスコンシン アラムニ リサーチ ファンデーション | 2−メチレン−1α−ヒドロキシ−19,21−ジノルビタミンD3類縁体およびその使用 |
MX2008012913A (es) * | 2006-04-06 | 2009-03-06 | Wisconsin Alumni Res Found | 2-metilen-1a,25-dihidroxi-18,19,21-trinorvitamina d3 y sus usos. |
WO2007118198A2 (en) | 2006-04-06 | 2007-10-18 | Wisconsin Alumni Research Foundation | 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
AU2007298673A1 (en) | 2006-04-06 | 2008-03-27 | Wisconsin Alumni Research Foundation | 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof |
EP2001841B1 (de) * | 2006-04-06 | 2012-06-13 | Wisconsin Alumni Research Foundation | 2-methylen-1-alpha-hydroxy-18,19,21-trinorvitamin-d3-analoge und deren verwendungen |
US7538098B2 (en) * | 2006-04-06 | 2009-05-26 | Wisconsin Alumni Research Foundation | 19-nor-vitamin D analogs with 1,2 or 3,2 heterocyclic ring |
US7763598B2 (en) * | 2006-04-10 | 2010-07-27 | Wisconsin Alumni Research Foundation | 1α-hydroxy-2-(3′-hydroxypropylidene)-19-nor-vitamin D compounds with a 1,1-dimethylpropyl side chain |
NZ575159A (en) * | 2006-09-28 | 2012-04-27 | Wisconsin Alumni Res Found | 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
EP2069297A1 (de) * | 2006-09-28 | 2009-06-17 | Wisconsin Alumni Research Foundation | 2-methylen-(20r,25s)-19,27-dinor-(22e)-vitamin-d-analoga |
AU2008345083B2 (en) * | 2007-12-28 | 2014-05-08 | Wisconsin Alumni Research Foundation | (20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs |
AU2008345085A1 (en) * | 2007-12-28 | 2009-07-09 | Wisconsin Alumni Research Foundation | 2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs |
MX2010007264A (es) * | 2007-12-28 | 2011-03-15 | Wisconsin Alumni Res Foundation Star | Análogos de vitamina d 2-metilen-(20s, 25r)-19, 26-dinor. |
EP2240439B1 (de) * | 2007-12-28 | 2015-03-18 | Wisconsin Alumni Research Foundation | (20s)-23,23-difluor-2-methylen-19-norbishomopregnacalciferol-vitamin-d-analoga |
AU2008345086B2 (en) * | 2007-12-28 | 2014-02-13 | Wisconsin Alumni Research Foundation | 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogs |
WO2009111695A1 (en) * | 2008-03-06 | 2009-09-11 | Wisconsin Alumni Research Foundation | Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin d compound |
US7893043B2 (en) * | 2008-07-10 | 2011-02-22 | Wisconsin Alumni Research Foundation | 2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs |
US8222236B2 (en) * | 2008-07-10 | 2012-07-17 | Wisconsin Alumni Research Foundation | 2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs |
US8193170B2 (en) * | 2008-07-10 | 2012-06-05 | Wisconsin Alumni Research Foundation | 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs |
US7888339B2 (en) * | 2008-07-10 | 2011-02-15 | Wisconsin Alumni Research Foundation | 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs |
US8399439B2 (en) * | 2008-07-10 | 2013-03-19 | Wisconsin Alumni Research Foundation | 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs |
US7648974B1 (en) * | 2008-07-10 | 2010-01-19 | Wisconsin Alumni Research Foundation | 19-nor-vitamin D analogs with 3,2-dihydrofuran ring |
US7713953B2 (en) * | 2008-07-10 | 2010-05-11 | Wisconsin Alumni Research Foundation | 2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs |
US7879829B2 (en) * | 2008-07-10 | 2011-02-01 | Wisconsin Alumni Research Foundation | 19-nor-vitamin D analogs with 1,2-dihydrofuran ring |
US8217023B2 (en) | 2009-10-02 | 2012-07-10 | Wisconsin Alumni Research Foundation | 19-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring |
MX2012003882A (es) | 2009-10-02 | 2012-06-25 | Wisconsin Alumni Res Found | Analogos de 1-desoxi-2-metileno-19-nor-vitamina d y sus usos. |
AU2010300528B2 (en) | 2009-10-02 | 2016-02-11 | Wisconsin Alumni Research Foundation | (20S,22E)-2-methylene-19-nor-22-ene-1alpha,25-dihydroxyvitamin D3 analogs |
EP2556053B1 (de) * | 2010-03-23 | 2015-07-29 | Wisconsin Alumni Research Foundation | (20s)-2-methylen-19-nor-22-dimethyl-1alpha,25-dihydroxyvitamin d3 und (20r)-2-methylen-19-nor-22-dimethyl-1alpha,25-hydroxyvitamin d3 |
US8664206B2 (en) | 2010-03-23 | 2014-03-04 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 |
EP2556054B1 (de) * | 2010-03-23 | 2017-09-27 | Wisconsin Alumni Research Foundation | Diastereomere von 2-methylen-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3 |
WO2012065050A1 (en) | 2010-11-12 | 2012-05-18 | Wisconsin Alumni Research Foundation | 22-haloacetoxy-homopregnacalciferol analogs and their uses |
US9290447B2 (en) | 2011-05-03 | 2016-03-22 | Wisconsin Alumni Research Foundation | (20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their uses |
WO2012158794A1 (en) | 2011-05-17 | 2012-11-22 | Wisconsin Alumni Research Foundation | N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses |
EP2714656B1 (de) | 2011-06-03 | 2017-05-03 | Wisconsin Alumni Research Foundation | (22e) -2-methylen-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin-d3-derivate |
JP6035331B2 (ja) * | 2011-06-14 | 2016-11-30 | ウイスコンシン アラムニ リサーチ ファンデーション | 3−デスオキシ−2−メチレン−19−ノル−ビタミンd類似体およびそれらの使用 |
WO2013003307A1 (en) | 2011-06-28 | 2013-01-03 | Wisconsin Alumni Research Foundation | 2-methylene-(22e)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs |
WO2013012644A1 (en) | 2011-07-18 | 2013-01-24 | Wisconsin Alumni I Research Foundation | 2-methylene-20(21)-dehydro-19,24,25,26,27,-pentanor-vitamin d analogs |
JP6072811B2 (ja) * | 2011-10-21 | 2017-02-01 | ウイスコンシン アラムニ リサーチ ファンデーション | 2−メチレン−ビタミンd類似体およびそれらの使用 |
EP2768804B1 (de) * | 2011-10-21 | 2018-02-28 | Wisconsin Alumni Research Foundation | 2-methylen-vitamin-d-analoge und ihre verwendungen |
US8785422B2 (en) | 2012-06-06 | 2014-07-22 | Wisconsin Alumni Research Foundation | A-ring modified 19-nor-vitamin D analogs and their uses |
US9416102B2 (en) | 2013-01-23 | 2016-08-16 | Wisconsin Alumni Research Foundation | (22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4539256A (en) * | 1982-09-09 | 1985-09-03 | Minnesota Mining And Manufacturing Co. | Microporous sheet material, method of making and articles made therewith |
US4666634A (en) | 1984-12-05 | 1987-05-19 | Chugai Seiyaku Kabushiki Kaisha | vitamin D3 derivatives having a substituent at 2-position |
US4800198A (en) | 1985-04-23 | 1989-01-24 | Wisconsin Alumni Research Foundation | Method of inducing the differentiation of malignant cells with secosterol |
CA1333616C (en) | 1989-03-09 | 1994-12-20 | Hector F. Deluca | 19-nor-vitamin d compounds |
US5459136A (en) | 1990-08-24 | 1995-10-17 | Wisconsin Alumni Research Foundation | Methods using vitamin D compounds for improvement of skin conditions |
US5089641A (en) | 1991-03-11 | 1992-02-18 | Wisconsin Alumni Research Foundation | Synthesis of 1α-hydroxy-secosterol compounds |
JP2898882B2 (ja) | 1993-04-05 | 1999-06-02 | ウイスコンシン アラムナイ リサーチ フオンデーシヨン | 2−位に置換基を有する19−ノル−ビタミンd3 化合物 |
US5877168A (en) | 1995-02-10 | 1999-03-02 | Chugai Seiyaku Kabushiki Kaisha | Vitamin D derivative with substituent at the 2β-position |
IL118156A (en) * | 1995-05-09 | 2001-08-26 | Duphar Int Res | Vitamin d compounds, their preparation and pharmaceutical compositions containing them |
US5840718A (en) * | 1997-03-06 | 1998-11-24 | Hoffmann-La Roche Inc. | 22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol |
US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
US5945410A (en) | 1997-03-17 | 1999-08-31 | Wisconsin Alumni Research Foundation | 2-alkyl-19-nor-vitamin D compounds |
-
2001
- 2001-06-11 MX MXPA03001969A patent/MXPA03001969A/es active IP Right Grant
- 2001-06-11 PT PT01942154T patent/PT1315504E/pt unknown
- 2001-06-11 AU AU2001275445A patent/AU2001275445B2/en not_active Ceased
- 2001-06-11 BR BR0113703-4A patent/BR0113703A/pt active Pending
- 2001-06-11 JP JP2002524505A patent/JP4022144B2/ja not_active Expired - Lifetime
- 2001-06-11 WO PCT/US2001/018710 patent/WO2002020021A1/en active IP Right Grant
- 2001-06-11 ES ES01942154T patent/ES2227215T3/es not_active Expired - Lifetime
- 2001-06-11 US US09/878,438 patent/US6440953B1/en not_active Expired - Fee Related
- 2001-06-11 AU AU7544501A patent/AU7544501A/xx active Pending
- 2001-06-11 NZ NZ524657A patent/NZ524657A/xx not_active IP Right Cessation
- 2001-06-11 DE DE60105035T patent/DE60105035T2/de not_active Expired - Lifetime
- 2001-06-11 AT AT01942154T patent/ATE273709T1/de not_active IP Right Cessation
- 2001-06-11 EP EP01942154A patent/EP1315504B1/de not_active Expired - Lifetime
- 2001-06-11 KR KR1020037003435A patent/KR100672886B1/ko not_active IP Right Cessation
- 2001-06-11 IL IL15469901A patent/IL154699A0/xx unknown
- 2001-06-11 CA CA002420026A patent/CA2420026C/en not_active Expired - Fee Related
- 2001-06-11 CN CNA018185193A patent/CN1473048A/zh active Pending
-
2002
- 2002-06-07 US US10/165,123 patent/US6579861B2/en not_active Expired - Lifetime
-
2003
- 2003-03-02 IL IL154699A patent/IL154699A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2002020021A1 (en) | 2002-03-14 |
MXPA03001969A (es) | 2003-06-24 |
CA2420026A1 (en) | 2002-03-14 |
IL154699A0 (en) | 2003-10-31 |
CA2420026C (en) | 2010-01-19 |
ATE273709T1 (de) | 2004-09-15 |
DE60105035T2 (de) | 2005-08-18 |
EP1315504B1 (de) | 2004-08-18 |
CN1473048A (zh) | 2004-02-04 |
JP2004512276A (ja) | 2004-04-22 |
AU7544501A (en) | 2002-03-22 |
IL154699A (en) | 2010-05-17 |
US6579861B2 (en) | 2003-06-17 |
EP1315504A1 (de) | 2003-06-04 |
ES2227215T3 (es) | 2005-04-01 |
BR0113703A (pt) | 2003-07-22 |
US20020052350A1 (en) | 2002-05-02 |
JP4022144B2 (ja) | 2007-12-12 |
KR100672886B1 (ko) | 2007-01-24 |
NZ524657A (en) | 2004-12-24 |
US20020183289A1 (en) | 2002-12-05 |
KR20030032015A (ko) | 2003-04-23 |
US6440953B1 (en) | 2002-08-27 |
AU2001275445B2 (en) | 2006-07-27 |
PT1315504E (pt) | 2004-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE273709T1 (de) | 1alpha-hydroxy-2-methylene-19-nor- homopregnacalciferol und seine therapeutische verwendungen | |
HK1077508A1 (en) | 1-Alpha-hydroxy-2-methylene-19-nor-pregnacal ciferol and its uses | |
DE60324909D1 (de) | (20s)-1alpha-hydroxy-2alpha-methyl und 2beta-methyl-19-nor vitamin d3 und ihre verwendung | |
HK1077804A1 (en) | (20S)-1Alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses | |
MX2007006262A (es) | 2-metilen-19-nor-1a-hidroxi-17-en homopregnacalciferol y sus usos. | |
MX2007006263A (es) | Analogos 2a-metil y 2??-metil de 19,26,27-trinor-(20s)-1a- hidroxivitamina d3 y sus usos. | |
DE602005021245D1 (de) | 2-methylen-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and dessen verwendungen | |
WO2006057899A3 (en) | 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses | |
ATE472528T1 (de) | 2-methylen-18,19-dinor-1alfa-hydroxy- homopregnacalciferol und dessen verwendungen | |
ATE552239T1 (de) | 2-methylen-20-methyl-19,24,25,26,27-pentanor- vitamin-d-analoga | |
ATE552238T1 (de) | 2-methylen-(20s,25s)-19,27-dinor-(22e)-vitamin- - analoga | |
WO2006057902A3 (en) | 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses | |
WO2009086439A3 (en) | 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs | |
DE602007012216D1 (de) | 1-alpha-hydroxy-2-(3'-hydroxypropyliden)-19-nor-vitamin-d-verbindungen mit einer 1,1-dimethylpropyl-seitenkette |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |